Ruxolitinib withdrawal due to the COVID-19. | Leukemia;35(4): 1218, 2021 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Ruxolitinib withdrawal due to the COVID-19.

Lucijanic, Marko; Kusec, Rajko.

Lucijanic M; Hematology Department, University Hospital Dubrava, Zagreb, Croatia. markolucijanic@yahoo.com.
Kusec R; University of Zagreb School of Medicine, Zagreb, Croatia. markolucijanic@yahoo.com.

Leukemia ; 35(4): 1218, 2021 04.

Article in English | MEDLINE | ID: covidwho-1139731

Subject(s)

COVID-19; Neoplasms; Humans; Nitriles; Pyrazoles/adverse effects; Pyrimidines; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Limits: Humans Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2021 Document Type: Article Affiliation country: S41375-021-01214-4

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Limits: Humans Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2021 Document Type: Article Affiliation country: S41375-021-01214-4